Acrux LimitedASX: ACR

Appendix 4E and 2018 Financial Report

· Issued by Acrux Limited

Filed with ASX · · 56 pages · English

This announcement comprises information required by the Australian Securities Exchange (‘ASX’) Listing Rule 4.3A. For more information, please contact: General enquiries Michael Kotsanis CEO & Managing Director Investor enquiries P: + 61 3 8379 0100 E: michael.kotsanis@acrux.com.au Anthony England Vesparum Capital P: +61 3 8582 4800 E: acrux@vesparum.com About Acrux Acrux (ASX: ACR) is a pharmaceu

Acrux Limited on 6ix

In the deck

Earlier from Acrux

Later from Acrux

All Acrux news releases